Author Archive: Tracy Cooley

Tracy Cooley

Tracy serves as the Director of Events Communications and handles all communications for BIO’s events and emerging company policy issues. She loves blogging and podcasting on all things biotech and believes in the great potential of the industry, looking for every opportunity to spread the message far and wide. Nearly everyone in her family is a golfer, and as such, she has what many people have called a “natural” swing. Sometimes she even hits the ball. Tracy just finished her ninth marathon, and has nearly mastered the skill of one-foot-in-front-of-the-other (usually, sometimes the laces get in the way). The joy of her life is her five-year-old daughter Josephine.

Latest Posts

Science Can Change the World

REX Bionic legs

Each day, scientists in labs around the world seek solutions to the most pressing problems – poverty, hunger, disease and climate change – since they believe in a better world through scientific innovation. These unsung heroes are celebrated in a new Royal DSM campaign – Bright Science. Brighter Living. Their stories can help amplify our messages to the public, policymakers, stakeholders, government and others on the importance of science to benefit society. We support and applaud the work of scientists Read More >

Environmental & Industrial, Food And Agriculture, Health  |  Leave a comment  |  Email This Post
Tags: , , ,

The Bio Report: What a Decade of Investment Tells Us About the Health of Biotech

Emerging Therapeutic Company Investment and Deal Trends

In this podcast, The Bio Report’s Daniel Levine interviews BIO’s Dave Thomas on the recent release of a new BIO Industry Analysis report – Emerging Therapeutic Company Investment and Deal Trends – highlighting ten years (2005-2014) of biotechnology funding and deal making across five areas: venture capital, IPOs, follow-on public offerings, licensing, and acquisitions. The report also offers a first-time look at the degree of collaboration across the industry’s clinical pipeline. Some of the key findings Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , , ,

ASCO Publishes New “Value Framework” for Cancer Treatment Options

medicine

On Monday, the American Society of Clinical Oncology (ASCO) published “A Framework to Assess the Value of Cancer Treatment Options” in the Journal of Clinical Oncology intended to ‘assess the value of new cancer therapies based on treatment benefits, toxicities, and costs.’ The framework, developed by the ASCO Value in Cancer Care Task Force, is intended to ‘ultimately serve as the basis for user-friendly, standardized tools that physicians can use with their patients to discuss the relative value Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , ,

Dr. Eric Topol’s Insights on Wearables, Smart Phones, Digital Medicine Revolution

ET

Dr. Eric Topol, director of the Scripps Translational Science Institute, is widely recognized for many things: as a renowned cardiologist, #1 Most Influential Physician Executive in the United States by Modern Healthcare, “Rock Star of Science” by GQ, author of several books, and the top authority on digital medicine, but who knew he was also a comedian? Topol shared his views with the BIO 2015 keynote luncheon audience in an informative and humorous way. Using videos Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , ,

Complexities of Rare Diseases Take the Spotlight at BIO

Orphan Drugs

Global Genes Founder & CEO Nicole Boice opened the BIO 2015 Orphan & Rare Disease Track by addressing a packed session with a simple, powerful statement: “We’re all working to eliminate the challenges of rare diseases, but patients and their advocates aren’t always equipped to fight.” Organizations like Global Genes help families affected by rare disease by connecting them with much needed tools and resources. By better understanding the definition of a “rare” disease, industry Read More >

Business and Investments, Events, Health, Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , ,